Controlled Substances: Orders, Purchases and Sales (Federal)

FACT SHEET

Legislative References:

A fact sheet summarizes relevant legislation in one place. Registrants are reminded to refer to legislation for full context.

Additional references:

Background

Controlled substances are regulated federally by Health Canada and the Office of Controlled Substances (OCS). The Controlled Drugs and Substances Act (CDSA) provides a legislative framework aimed at controlling access to substances that can alter mental processes and produce harm to the health of an individual and/or society when diverted or misused.

The Narcotic Control Regulations (NCR), the Benzodiazepines and Other Targeted Substances Regulations (BOTSR) made under the CDSA, and Part G of the Food and Drug Regulations (FDR-G) made under the Food and Drugs Act govern the ordering and selling or providing of each class of controlled substances by pharmacists and hospitals from licensed dealers and each other.

Definitions

Controlled Substance: A substance included in Schedule I, II, III, IV or V of the federal Controlled Drug and Substances Act (CDSA). These substances are also listed in the schedules to regulations made under the Act as either narcoticscontrolled drugs, or benzodiazepines and other targeted substances. (CDSA)

Licensed Dealer: An individual or corporation granted a licence from the federal Minister of Health to conduct activities with (e.g., make, sell, provide, transport, deliver, etc.) the controlled substances specified in their licence. (NCR s.9)

Signing Authority
  • In a community pharmacy, federal regulations permit a pharmacist to order and sign for receipt of controlled substances.
    • This may also apply to a pharmacist in certain non-accredited workplaces, such as those under the jurisdiction of the federal or provincial governments.
  • In a hospital pharmacy, federal regulations permit the pharmacist in charge to order and sign for receipt of controlled substances.
    • The person in charge of the hospital (CEO) may designate another pharmacist or practitioner to have controlled substance signing authority.
Signing Authority Exceptions

Controlled substances cannot be ordered or received by a pharmacist without signing authority, which occurs in the following circumstances:

Health Canada Notices of Restriction

OCP Discipline Findings

  • The panel of the Discipline Committee has imposed terms, conditions or limitations (TCLs) on the pharmacist’s certificate of registration prohibiting them from having signing authority for any controlled substances.
  • Access the College’s public register for the pharmacy professional and check for TCLs under “Concerns”
Orders, Purchases & Sales (other than pursuant to a patient-specific prescription)

From a licensed dealer

  • A licensed dealer may sell a controlled substance to a pharmacist[1] or hospital[2] upon receipt of a written order signed and dated by a pharmacist with signing authority, specifying the name and quantity of the controlled substance.
  • When a narcotic, controlled drug, or targeted substance is ordered verbally, if permitted by regulations[4], the licensed dealer must obtain a receipt signed and dated by a pharmacist with signing authority, specifying the name and quantity of controlled substance received, within five (5) working days after filling the order.
    • If this requirement is not met, the licensed dealer must withhold future verbal orders from the pharmacist[5].

Sale, Provision or Transfer for Emergency Supply

  • Pharmacist to pharmacist
    • A pharmacist may sell or provide a narcotic or controlled drug to another pharmacist on receipt of a signed and dated written order, where the quantity is specified as being required for emergency purposes[6].
    • A pharmacist may sell or provide, a benzodiazepine or other targeted substance to another pharmacist who states in writing or verbally that it is required because of a delay or shortfall in an order placed with a licensed dealer[7].
  • Hospital to/from pharmacist
    • A pharmacist may sell or provide a narcotic or controlled drug to a hospital if the pharmacist receives a written order for the narcotic signed and dated by ta pharmacist (or other practitioner) with signing authority[8].
    • The person in charge of a hospital may permit a narcotic or controlled drug to be sold or provided to a pharmacist for emergency purposes, on receipt of a written order signed and dated by a pharmacist with signing authority[9].
    • A pharmacist may sell or provide a benzodiazepine or other targeted substance to a hospital if the written or verbal order is placed by a pharmacist (or other practitioner) with signing authority [10].
  • Hospital to hospital
    • The person in charge of a hospital may provide a narcotic or controlled drug to another hospital for emergency purposes, on receipt of a written order signed and dated by a pharmacist (or other practitioner) with signing authority in the other hospital[11].
    • A hospital pharmacist may sell or provide a benzodiazepine or other targeted substance to another hospital, on receipt of an order stating that it is required because of a delay or shortfall in an order placed with a licensed dealer or pharmacist, from a pharmacist (or other practitioner) with signing authority in the other hospital.

Note: Under the CDSA, s.2(1), the definition of “provide” also means “to transfer”. Health Canada advises that these provisions are not intended to be used for stock management purposes. Typically, the quantities involved would be limited to what is necessary to fill a single prescription. An emergency order transaction must be captured by both pharmacist’s respective receiving and dispensing records[12].


Published: 
December 2024
Version #: 2.2

College Contact: Pharmacy Practice

Revision History
Version # Date Action
1 August 2012 Published as “Narcotic Purchases”
2 October 2021
  • Changed title to Controlled Substances – Orders, Purchases & Sales (Federal)
  • Inclusive of all controlled substances and hospitals
  • Added Health Canada notice of restriction
2.1 March 2022 Added emergency transfer note from Health Canada Guidance Document
2.2 March 2023 Minor content update from revised Health Canada Guidance Document
3.0 December 2024 Updated to reflect removal of controlled substance (“narcotic”) signers from OCP By law No.7. The College will no longer gather or post this information on the public register.

 

  1. NCR, s 25.1, FDR, s G.02.052, BOTSR, s 32
  2. NCR, s 25.3, FDR, s G.02.054, BOTSR, s 32, 63(2) 
  3. NCR, s 25.6, FDR, s G.02.057, BOTSR, s 33 
  4. A verbal prescription narcotic or controlled drug in Part II or III of the Schedule to Part G 
  5. NCR, s 25.7, FDR, s G.02.058 
  6. NCR, s45(1)(2), FDR G.03.014 (b) 
  7. BOTSRs 55(1)(b)(ii) 
  8. NCR, s35, FDR s G.03.005 
  9. NCR s65(4)(5.1), ), FDR s G.05.003 (4) 
  10. BOTSRs 55(1)(b)(iii) 
  11. NCR, s65(3)(5.1), FDR s G.05.003 (3) 
  12. Controlled substances guidance for community pharmacists: security, inventory reconciliation and record-keeping (Health Canada January 2023) 
  13. NCR s 25.1(2), 32